October 29, 2026 at 11:16 AM UTC
LIGAND PHARMACEUTICALS INC reports financial results in SEC 8-K
LIGAND PHARMACEUTICALS INC filed an 8-K covering results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: October 29, 2026 at 11:14 AM UTC
Open official source